公开(公告)号：US20240226264A1

公开(公告)日：2024-07-11

申请号：US18396787

申请日：2023-12-27

申请人： Boehringer Ingelheim Vetmedica GmbH ,  lowa State University Research Foundation, Inc.

发明人： Arun IYER ,  Luis Alejandro Hernandez ,  Abby Patterson ,  Bailey Arruda ,  Luis Gabriel Gimenez-Lirola ,  Dave Michael Anstrom ,  Eric M. Vaughn ,  Pablo E Pineyro Pineiro ,  Troy James Kaiser ,  Joseph Ralph Hermann

IPC分类号： A61K39/12 ,  A61K39/00 ,  A61K39/23 ,  A61P31/20 ,  A61P37/04

CPC分类号： A61K39/12 ,  A61K39/23 ,  A61P31/20 ,  A61P37/04 ,  A61K2039/545 ,  A61K2039/552 ,  A61K2039/70 ,  C12N2750/10034 ,  C12N2750/10071 ,  C12N2750/14034

摘要： The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 3 (PCV3) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV3 infection.